Skip to main content

Advertisement

SpringerLink
Log in

Molecular Mechanisms of Hormone Resistance of Breast Cancer

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

More than 70% malignant mammary tumors contain steroid hormone receptors; this suggests the possibility of hormone therapy in the majority of patients with breast cancer (BC). The main cause of ineffi ciency of hormone therapy in BC is hormone resistance (tumor resistance to hormonal cytostatics). Here we discuss the main mechanisms of hormone resistance of BC and the mechanisms underlying the formation of hormone resistance of the tumors are analyzed at the molecular level. The data on the signal pathways of estrogen receptors (ER), the key regulators of BC cell proliferation, are presented. The most important factors of BC hormone resistance are: high activity/expression of receptor tyrosine kinases; high activity of proteins regulating cell defense mechanisms (Akt PI3K, mTOR); changes in the activities of cell cycle regulator proteins (Myc, c-Fos, Cyclin D1). Our experiments have demonstrated that estrogen-independent BC cell growth is supported by VEGF/VEGFR2 and EGF/EGFR mitogenic signal pathways. Our data indicate that NF-κB transcription factor is directly involved in the regulation of hormone-resistant BC cell growth and survival, while NF-κB suppression determines cell sensitivity to apoptotic activity of antitumor compounds. On the whole, the results indicate good prospects of using EGFR, HER-2/neu, mTOR, VEGFR, PI3K/Akt molecular pathways as targets for BC therapy, including therapy for BC resistant forms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. J. Adams, P. J. Carder, S. Downey, et al., Cancer Res., 60, No. 11, 2898–2905 (2000).

    PubMed  CAS  Google Scholar 

  2. S. Ahmad, N. Singh, and R. I. Glazer, Biochem. Pharmacol., 58, No. 3, 425–430 (1999).

    PubMed  CAS  Google Scholar 

  3. S. Attwell, C. Roskelley, and S. Dedhar, Oncogene, 19, No. 33, 3811–3815 (2000).

    PubMed  CAS  Google Scholar 

  4. T. Bachleitner-Hofmann, B. Pichler-Gebhard, M. Rudas, et al., Clin. Cancer Res., 8, No. 11, 3427–3432 (2002).

    PubMed  CAS  Google Scholar 

  5. H. Bando, H. A. Weich, M. Brokelman, et al., Brit. J. Cancer, 92, No. 3, 553–561 (2005).

    PubMed  CAS  Google Scholar 

  6. A. Barton-Gonzalez and I. Casto-Romero, Biochem. Cell Biol., 82, No. 2, 335–342 (2004).

    Google Scholar 

  7. V. Bartella, P. De Marco, R. Malaguarnera, et al., Cell Signal, 24, No. 8, 1515–1521 (2012).

    PubMed  CAS  Google Scholar 

  8. J. Baselga, M. Campone, M. Piccard, et al., N. Engl. J. Med., 366, No. 6, 520–529 (2012).

    PubMed  CAS  Google Scholar 

  9. L. M. Berstein, H. Zheng, W. Yue, et al., Endocr. Relat. Cancer, 10, No. 2, 267–277 (2003).

    PubMed  CAS  Google Scholar 

  10. D. K. Biswas, S. Singh, Q. Shi, et al., Sci. STKE , 2005, No. 288, pe27 (2005).

    PubMed  Google Scholar 

  11. L. Bogin and H. Degani, Cancer Res., 62, No. 7, 1948–1951 (2002).

    PubMed  CAS  Google Scholar 

  12. A. R. Brassier, Cardiovasc. Toxicol., 6, No. 2, 111–130 (2006).

    Google Scholar 

  13. D. J. Britton, I. R. Hutcheson, J. M. Knowlden, et al., Breast Cancer Res. Treat., 96, No. 2, 131–146 (2006).

    PubMed  CAS  Google Scholar 

  14. N. Brunner, B. Boysen, S. Jirus, et al., Cancer Res., 57, No. 16, 3486–3493 (1997).

    PubMed  CAS  Google Scholar 

  15. B. M. Burgering and P. J. Coffer, Nature, 376, 599–602 (1995).

    PubMed  CAS  Google Scholar 

  16. H. Butteau-Lozano, M. Ancelin, B. Lardeux, et al., Cancer Res., 62, No. 17, 4977–4984 (2002).

    Google Scholar 

  17. R. A. Campbell, P. Bhat-Nakshatri, N. M. Patel, et al., J. Biol. Chem., 276, No. 13, 9817–9824 (2001).

    PubMed  CAS  Google Scholar 

  18. F. Cardoso, V. Durbecq, J. F. Laes, et al., Mol. Cancer Ther., 5, No. 12, 3042–3051 (2006).

    PubMed  CAS  Google Scholar 

  19. A. Cavazzoni, M. Bonelli, C. Fumaroma, et al., Cancer Lett., 323, No. 1, 77–87 (2012).

    PubMed  CAS  Google Scholar 

  20. A. S. Clark, K. West, S. Streicher, and P. A. Dennis, Mol. Cancer Ther., 1, No. 9, 707–717 (2002).

    PubMed  CAS  Google Scholar 

  21. R. Clarke, M. C. Liu, K. B. Bouker, et al., Oncogene, 22, No. 47, 7316–7339 (2003).

    PubMed  CAS  Google Scholar 

  22. D. Coradini, C. Pellizzaro, A. Speranza, and M. G. Daidone, Cell. Mol. Life Sci., 61, No. 1, 76–82 (2004).

    PubMed  CAS  Google Scholar 

  23. M. Cristofanilli, V. Valero, A. Mangalik, et al., Clin. Cancer Res., 16, No. 6, 1904–1914 (2010).

    PubMed  CAS  Google Scholar 

  24. H. Dotzlaw, E. Leygue, P. H. Watson, and L. C. Murphy, Cancer Res., 59, No. 3, 529–532 (1999).

    PubMed  CAS  Google Scholar 

  25. R. Duan, W. Porter, and S. Safe, Endocrinology, 139, No. 4, 1981–1990 (1998).

    PubMed  CAS  Google Scholar 

  26. S. Elbauomy Elsheikh, A. R. Green, M. B. Lambors, et al., Breast Cancer Res., 9, No. 2, R23 (2007).

    PubMed  Google Scholar 

  27. M. J. Evans, A. Eckert, K. Lai, et al., Circ. Res., 89, No. 9, 823–830 (2001).

    PubMed  CAS  Google Scholar 

  28. J. Faridi, L. Wang, G. Endemann, and R. A. Roth, Clin. Cancer Res., 9, No. 8, 2933–2939 (2003).

    PubMed  CAS  Google Scholar 

  29. N. Ferrara, Exs, No. 94, 209–231 (2005).

  30. J. A. Foekens, H. A. Peters, N. Grebenchtchikov, et al., Cancer Res., 61, No. 14, 5407–5414 (2001).

    PubMed  CAS  Google Scholar 

  31. E. M. Fox, C. L. Artega, and T. W. Miller, Front. Oncol., 2, 145 (2012).

    PubMed  Google Scholar 

  32. T. F. Franke, C. P. Hornik, L. Segev, et al., Oncogene, 22, No. 56, 8983–8998 (2003).

    PubMed  CAS  Google Scholar 

  33. J. Frasor, A. Weaver, M. Pradhan, et al., Cancer Res., 69, No. 23, 8918–8925 (2009).

    PubMed  CAS  Google Scholar 

  34. I. Galetic, M. Andjelkovic, R. Meier, et al., Pharmacol. Ther., 82, Nos. 2-3, 409–425 (1999).

    PubMed  CAS  Google Scholar 

  35. S. Garvin and C. Dabrosin, Cancer Res., 63, No. 24, 8742–8748 (2003).

    PubMed  CAS  Google Scholar 

  36. J. M. Gee, M. E. Harper, I. R. Hutcheson, et al., Endocrinology, 144, No. 11, 5105–5117 (2003).

    PubMed  CAS  Google Scholar 

  37. P. Guo, Q. Fang, H. Q. Tao, et al., Cancer Res., 63, No. 15, 4684–4691 (2003).

    PubMed  CAS  Google Scholar 

  38. M. C. Gutierrez, S. Detre, S. Johnston, et al., J. Clin. Oncol., 23, No. 11, 2469–2476 (2005).

    PubMed  CAS  Google Scholar 

  39. E. Gutteridge, A. Agrawal, R. Nicholson, et al., Int. J. Cancer, 126, No. 8, 1806–1816 (2010).

    PubMed  CAS  Google Scholar 

  40. W. Han and H. W. Lo, Cancer Lett., 318, No. 2, 124–134 (2012).

    PubMed  CAS  Google Scholar 

  41. D. C. Harnish, M. S. Scicchitano, S. J. Adelman, et al., Endocrinology, 141, No. 9, 3403–3411 (2000).

    PubMed  CAS  Google Scholar 

  42. J. R. Harris, Diseases of the Breast, Philadelphia (1996).

  43. B. E. Henderson, B. A. J. Ponder, and R. K. Ross, Hormones, Genes, and Cancer, Oxford; New York (2003).

    Google Scholar 

  44. H. J. Hugo, M. I. Kokkinos, T. Blick, et al., Cell Tissues Organs, 193, Nos. 1-2, 23–40 (2011).

    Google Scholar 

  45. P. Jalava, T. Kuopio, R. Huovinen, et al., Anticancer Res., 25, No. 3c, 2535–2542 (2005).

    PubMed  CAS  Google Scholar 

  46. J. K. Jenkins, S. Suwannaroj, K. B. Elbourne, et al., Int. J. Immunopharmacol., 1, No. 11, 1897–1911 (2001).

    CAS  Google Scholar 

  47. H. P. Jiang, R. Y. Teng, Q. Wang, et al., Chin. Med. J. (Engl.) 121, No. 11, 1025–1031 (2008).

    CAS  Google Scholar 

  48. W. Jin, L. Wu, K. Liang, et al., Brit. J. Cancer, 89, No. 1, 185–191 (2003).

    PubMed  CAS  Google Scholar 

  49. S. R. Johnston, G. Saccani-Jotti, I. E. Smith, et al., Cancer Res., 55, No. 15, 3331–3338 (1995).

    PubMed  CAS  Google Scholar 

  50. N. J. Jordan, J. M. Gee, D. Barrow, et al., Breast Cancer Res. Treat., 87, No. 2, 167–180 (2004).

    PubMed  CAS  Google Scholar 

  51. D. Y. Jun, H. S. Park, J. S. Kim, et al., Toxicol. Appl. Pharmacol., 231, No. 3, 401–412 (2008).

    PubMed  CAS  Google Scholar 

  52. D. Kajdaniuk, B. Marek, W. Foltyn, and B. Kos-Kudla, Endokrynol. Pol., 62, No. 5, 456–464 (2011).

    PubMed  CAS  Google Scholar 

  53. B. Kaufman, J. R. Mackey, M. R. Clemens, et al., J. Clin. Oncol., 27, No. 33, 5529–5537 (2009).

    PubMed  CAS  Google Scholar 

  54. H. Kawai, H. Li, P. Chun, et al., Oncogene, 21, No. 50, 7730–7739 (2002).

    PubMed  CAS  Google Scholar 

  55. J. M. Knowlden, I. R. Hutcheson, H. E. Jones, et al., Endocrinology, 144, No. 3, 1032–1044 (2003).

    PubMed  CAS  Google Scholar 

  56. M. A. Krasil’nikov, Vopr. Onkol., 50, No. 4, 399–405 (2004).

    PubMed  Google Scholar 

  57. Y. Kubota, Keio. J. Med., 61, No. 2, 47–56 (2012).

    PubMed  CAS  Google Scholar 

  58. R. Kumar, R. K. Vadlamudi, and L. Adam, Endocr. Relat. Cancer, 7, No. 4, 257–269 (2000).

    PubMed  CAS  Google Scholar 

  59. H. Kurokawa, A. E. Lenferink, J. F. Simpson, et al., Cancer Res., 60, No. 20, 5887–5894 (2000).

    PubMed  CAS  Google Scholar 

  60. W. Lan, A. Petznick, S. Heryati, et al., Ocul. Surf., 10, No. 3, 137–148 (2012).

    PubMed  Google Scholar 

  61. J. E. Lee, K. W. Chung, W. Han, et al., Anticancer Res., 24, No. 6, 3961–3964 (2004).

    PubMed  CAS  Google Scholar 

  62. J. S. Lewis, C. Osipo, K. Meeke, and V. C. Jordan, J. Steroid Biochem. Mol. Biol., 94, Nos. 1-3, 131–141 (2005).

    PubMed  CAS  Google Scholar 

  63. Y. Li, F. Ahmed, S. Ali, et al., Cancer Res., 65, No. 15, 6934–6942 (2005).

    PubMed  CAS  Google Scholar 

  64. J. Ling and R. Kumar, Cancer Lett., 322, No. 2, 119–126 (2012).

    PubMed  CAS  Google Scholar 

  65. H. Liu, E. S. Lee, C. Gajdos, et al., J. Natl. Cancer Inst., 95, No. 21, 1586–1597 (2003).

    PubMed  CAS  Google Scholar 

  66. Y. S. Lobanova, A. M. Shcherbakov, V. A. Shatskaya, et al., Mol. Cell Biochem., 324, Nos. 1-2, 65–71 (2009).

    PubMed  CAS  Google Scholar 

  67. Y. S. Lobanova, A. M. Shcherbakov, V. A. Shatskaya, and M. A. Krasil’nikov, Biochemistry (Mosc.), 72, No. 3, 320–327 (2007).

    CAS  Google Scholar 

  68. P. E. Lonning, P. D. Taylor, G. Anker, et al., Breast Cancer Res. Treat., 67, No. 2, 111–116 (2001).

    PubMed  CAS  Google Scholar 

  69. V. Ludovini, A. Sidoni, L. Pistola, et al., Breast Cancer Res. Treat., 81, No. 2, 159–168 (2003).

    PubMed  CAS  Google Scholar 

  70. G. Lurje and H. J. Lenz, Oncology, 77, No. 6, 400–410 (2009).

    PubMed  CAS  Google Scholar 

  71. P. Manders, L. V. Beex, V. C. Tjan-Heijnen, et al., Brit. J. Cancer, 87, No. 7, 772–778 (2002).

    PubMed  CAS  Google Scholar 

  72. P. Manders, L. V. Beex, V. C. Tjan-Heijnen, et al., Cancer, 98, No. 10, 2125–2132 (2003).

    PubMed  CAS  Google Scholar 

  73. P. Manders, L. V. Beex, V. C. Tjan-Heijnen, et al., Int. J. Oncol., 25, No. 2, 511–517 (2004).

    PubMed  CAS  Google Scholar 

  74. P. K. Marcom, C. Isaacs, L. Harris, et al., Breast Cancer Res. Treat., 102, No. 1, 43–49 (2007).

    PubMed  CAS  Google Scholar 

  75. R. A. McClelland, D. Barrow, T. A. Madden, et al., Endocrinology, 142, No. 7, 2776–2788 (2001).

    PubMed  CAS  Google Scholar 

  76. T. W. Miller, J. M. Balko, and C. L. Arteaga, J. Clin. Oncol., 29, No. 33, 4452–4461 (201).

  77. R. Moore and D. V. Faller, J. Endocrinol., Nov. 20 (2012) [Epub ahead of print].

  78. S. Mosselman, J. Polman, and R. Dijkema, FEBS Lett., 392, No. 1, 49–53 (1996).

    PubMed  CAS  Google Scholar 

  79. M. D. Mueller, J. L. Vigne, A. Minchenko, et al., Proc. Natl. Acad. Sci. USA, 97, No. 20, 10,972–10,977 (2000).

    CAS  Google Scholar 

  80. L. Nakopoulou, K. Stefanaki, E. Panayotopoulou, et al., Hum. Pathol., 33, No. 9, 863–870 (2002).

    PubMed  CAS  Google Scholar 

  81. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak, FASEB J., 13, No. 1, 9–22 (1999).

    PubMed  CAS  Google Scholar 

  82. R. I. Nicholson, I. R. Hutcheson, M. E. Harper, et al., Endocr. Relat. Cancer, 8, No. 3, 175–182 (2001).

    PubMed  CAS  Google Scholar 

  83. C. K. Osborne, P. Neven, L. Y. Dirix, et al., Clin. Cancer Res., 17, No. 5, 1147–1159 (2011).

    PubMed  CAS  Google Scholar 

  84. C. K. Osborne and R. Schiff, Ann. Rev. Med., 62, 233–247 (2011).

    PubMed  CAS  Google Scholar 

  85. C. Osipo, C. Gajdos, D. Cheng, and V. C. Jordan, J. Steroid Biochem. Mol. Biol., 93, Nos. 2-5, 249–256 (2005).

    PubMed  CAS  Google Scholar 

  86. C. Osipo, C. Gajdos, H. Liu, et al., J. Natl. Cancer Inst., 95, No. 21, 1597–1608 (2003).

    PubMed  CAS  Google Scholar 

  87. C. Osipo, H. Liu, K. Meeke, and V. C. Jordan, Exp. Biol. Med. (Maywood), 229, No. 8, 722–731 (2004).

    CAS  Google Scholar 

  88. R. Patel and H. Y. Leung, Curr. Pharm. Dis., 18, No. 19, 2672–2679 (2012).

    CAS  Google Scholar 

  89. P. P. Peethambaram, J. N. Ingle, V. J. Suman, et al., Breast Cancer Res. Treat, 54, No. 2, 117–122 (1999).

    PubMed  CAS  Google Scholar 

  90. D. J. Price, T. Miralem, S. Jiang, et al., Cell Growth Differ., 12, No. 3, 129–135 (2001).

    PubMed  CAS  Google Scholar 

  91. A. Ring and M. Dowsett, Endocr. Relat. Cancer, 11, No. 4, 643–658 (2004).

    PubMed  CAS  Google Scholar 

  92. R. P. Roop and C. X. Ma, Future Oncol., 8, No. 3, 273–292 (2012).

    PubMed  CAS  Google Scholar 

  93. J. K. Ruohola, E. M. Valve, M. J. Karkkainen, et al., Mol. Cell. Endocrinol., 149, Nos. 1-2, 29–40 (1999).

    PubMed  CAS  Google Scholar 

  94. L. Ryden, K. Jirstrom, P. O. Bendahl, et al., J. Clin. Oncol., 23, No. 21, 4695–4704 (2005).

    PubMed  CAS  Google Scholar 

  95. L. Ryden, M. Stendahl, H. Jonsson, et al., Breast Cancer Res. Treat., 89, No. 2, 135–143 (2005).

    PubMed  CAS  Google Scholar 

  96. D. S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno, Crit. Rev. Oncol. Hematol., 19, No. 3, 183–232 (1995).

    PubMed  CAS  Google Scholar 

  97. J. Sandholm, J. H. Kauppila, C. Pressey, et al., Breast Cancer Res. Treat., 132, No. 2, 411–419 (2012).

    PubMed  CAS  Google Scholar 

  98. R. J. Santen, R. X. Song, Z. Zhang, et al., Endocr. Relat. Cancer, 10, No. 2, 111–130 (2003).

    PubMed  CAS  Google Scholar 

  99. D. D. Sarbassov, D. A. Guertin, S. M. Ali, and D. M. Sabatini, Science, 307, 1098–1101 (2005).

    PubMed  CAS  Google Scholar 

  100. A. M. Scherbakov, O. E. Andreeva, V. A. Shatskaya, and M. A. Krasil’nikov, J. Cell. Biochem., 113, No. 6, 2147–2155 (2012).

    PubMed  CAS  Google Scholar 

  101. A. M. Scherbakov, Y. S. Lobanova, O. E. Andreeva, et al., Biosci. Rep., 31, No. 2, 137–143 (2011).

    PubMed  CAS  Google Scholar 

  102. A. M. Scherbakov, Y. S. Lobanova, V. A. Shatskaya, et al., Breast Cancer Res. Treat., 100, No. 1, 1–11 (2006).

    PubMed  CAS  Google Scholar 

  103. L. S. Schwartzberg, S. X. Franco, A. Florance, et al., Oncologist, 15, No. 2, 122–129 (2010).

    PubMed  Google Scholar 

  104. E. Seli, O. Guzeloglu-Kayisli, U. A. Kayisli, et al., Fertil. Steril., 88, No. 4, Suppl., 1190–1196 (2007).

    PubMed  Google Scholar 

  105. P. Seshacharyulu, M. P. Ponnusamy, D. Haridas, et al., Exp. Opin. Ther. Targets, 16, No. 1, 15–31 (2012).

    CAS  Google Scholar 

  106. A. M. Shcherbakov, Y. S. Lobanova, V. A. Shatskaya, et al., Byull. Exp. Biol. Med., 141, No. 3, 357–360 (2006).

    CAS  Google Scholar 

  107. K. Shostak and A. Chariot, Breast Cancer Res., 13, No. 4, 214 (2011).

    PubMed  Google Scholar 

  108. S. Singh, Q. Shi, S. T. Bailey, et al., Mol. Cancer Ther., 6, No. 7, 1973–1982 (2007).

    PubMed  CAS  Google Scholar 

  109. R. X. Song, G. Mor, F. Naftolin, et al., J. Natl. Cancer Inst., 93, No. 22, 1714–1723 (2001).

    PubMed  CAS  Google Scholar 

  110. R. X. Song and R. J. Santen, Apoptosis, 8, No. 1, 55–60 (2003).

    PubMed  CAS  Google Scholar 

  111. R. X. Song, Z. Zhang, G. Mor, and R. J. Santen, Apoptosis, 10, No. 3, 667–678 (2005).

    PubMed  CAS  Google Scholar 

  112. N. E. Sounni, L. Devy, A. Hajitou, et al., FASEB J., 16, No. 6, 555–564 (2002).

    PubMed  CAS  Google Scholar 

  113. G. E. Stoica, T. F. Franke, M. Moroni, et al., Oncogene, 22, No. 39, 7998–8011 (2003).

    PubMed  Google Scholar 

  114. A. Strom, J. Hartman, J. S. Foster, et al., Proc. Natl. Acad. Sci. USA, 101, No. 6, 1566–1571 (2004).

    PubMed  Google Scholar 

  115. J. E. Thompson and C. B. Thompson, J. Clin. Oncol., 22, No. 20, 4217–4226 (2004).

    PubMed  CAS  Google Scholar 

  116. M. Toi, H. Bando, T. Ogawa, et al., Int. J. Cancer, 98, No. 1, 14–18 (2002).

    PubMed  CAS  Google Scholar 

  117. N. Turner, A. Pearson, R. Sharpe, et al., Cancer Res., 70, No. 5, 2085–2094 (2010).

    PubMed  CAS  Google Scholar 

  118. S. J. Van Laere, I. Van der Auwera, G. G. Van den Eynden, et al., Brit. J. Cancer, 97, No. 5, 659–669 (2007).

    PubMed  Google Scholar 

  119. H. Wajant, K. Pfi zenmaier, and P. Scheurich, Cell Death Differ., 10, No. 1, 45–65 (2003).

    PubMed  CAS  Google Scholar 

  120. P. Walter, S. Green, G. Greene, et al., Proc. Natl. Acad. Sci. USA, 82, No. 23, 7889–7893 (1985).

    PubMed  CAS  Google Scholar 

  121. Y. Zhou, S. Eppenberger-Castori, U. Eppenberger, and C. C. Benz, Endocr. Relat. Cancer, 12, Suppl. 1, S37–S46 (2005).

    PubMed  CAS  Google Scholar 

  122. Early Breast Cancer Trialists’ Collaborative Group, Tamoxifen for Early Breast Cencer: An Overview of the Randomised Trials, Lancet, 351, 1451–1467 (1998).

Download references

Author information

Authors and Affiliations

  1. N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia

    A. M. Scherbakov, M. A. Krasil’nikov & N. E. Kushlinskii

Authors
  1. A. M. Scherbakov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Krasil’nikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. E. Kushlinskii
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. M. Scherbakov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 155, No. 3, pp. 363-376, March, 2013

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scherbakov, A.M., Krasil’nikov, M.A. & Kushlinskii, N.E. Molecular Mechanisms of Hormone Resistance of Breast Cancer. Bull Exp Biol Med 155, 384–395 (2013). https://doi.org/10.1007/s10517-013-2160-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2160-y

Key Words

Search

Navigation